Year: 2025
VANCOUVER, British Columbia, Jan. 09, 2025 (GLOBE NEWSWIRE) — Taseko Mines Limited (TSX: TKO; NYSE American: TGB; LSE: TKO) (“Taseko” or the “Company”) announces 2024 production from its 100% owned Gibraltar copper mine. Copper and molybdenum production for the year was 106 million pounds and 1.4 million pounds, respectively. Sales volumes for the year were 108 million pounds of copper and 1.4 million pounds of molybdenum.
In late December, the Company closed a transaction with Osisko Gold Royalties to amend the Gibraltar silver steam agreement, increasing the attributable silver percentage from 87.5% to 100%. In exchange, Taseko has received an additional cash payment of US$12.7 million.
Stuart McDonald, President & CEO of Taseko, commented, “Since completion of the planned major maintenance activities...
Amwell® divests virtual psychiatric care business to Avel eCare in all-cash transaction
Written by Customer Service on . Posted in Public Companies.
Divestment of Amwell Psychiatric Care intended to focus product portfolio on key growth initiatives
Company reiterates guidance for 2024
BOSTON, Jan. 09, 2025 (GLOBE NEWSWIRE) — Amwell® (NYSE: AMWL), a global leader in digital care, today announced it has sold its Amwell Psychiatric Care (APC) business to Avel eCare, a national leading provider of clinician-to-clinician telehealth services.
With the divestiture of APC, a virtual psychiatric care service that Amwell purchased in 2019, Amwell continues to sharpen its focus on key growth areas, driving greater efficiencies and fulfilling clients’ digital care ambitions. Throughout its nearly 20-year history, Amwell has continuously adapted to market demands by leveraging its technology and healthcare expertise to enable clients to deliver high-quality care. The company’s decision...
WALKER RIVER ANNOUNCES SIGNIFICANT GOLD INTERCEPTS INCLUDING 3.88 G/T OVER 77.72 METERS AT THE LAPON GOLD PROJECT
Written by Customer Service on . Posted in Public Companies.
Vancouver, B.C. , Jan. 09, 2025 (GLOBE NEWSWIRE) — Walker River Resources Corp. (“Walker” or the “Company”) (TSX-V: WRR) is pleased to announce additional assay results from the 2024 reverse circulation (“RC”) drill program at the Lapon Canyon portion of the Lapon Gold Project, in Mineral County, Nevada, 60 km SE of Yerington, NV.Highlights
From
To
Width*
GoldDrill Hole
(m)
(m)
(m)
(g/t)LC-24-117
74.68
152.4
77.72
3.88including
77.72
94.49
16.77
12.09and
100.58
112.78
12.2
4.08LC-24-118
68.58
128.02
59.44
1.96including
68.58
74.68
6.10
8.17LC-24-110
41.15
74.68
33.53
2.70including
45.72
57.91
12.19
5.99LC-24-113
21.34
48.77
27.43
2.58including
25.91
32.00
6.09
4.13...
Taseko Announces 2024 Production Results
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, Jan. 09, 2025 (GLOBE NEWSWIRE) — Taseko Mines Limited (TSX: TKO; NYSE American: TGB; LSE: TKO) (“Taseko” or the “Company”) announces 2024 production from its 100% owned Gibraltar copper mine. Copper and molybdenum production for the year was 106 million pounds and 1.4 million pounds, respectively. Sales volumes for the year were 108 million pounds of copper and 1.4 million pounds of molybdenum.
In late December, the Company closed a transaction with Osisko Gold Royalties to amend the Gibraltar silver steam agreement, increasing the attributable silver percentage from 87.5% to 100%. In exchange, Taseko has received an additional cash payment of US$12.7 million.
Stuart McDonald, President & CEO of Taseko, commented, “Since completion of the planned major maintenance activities...
Freshworks to Announce Fourth Quarter and Full Year 2024 Financial Results on February 11, 2025
Written by Customer Service on . Posted in Public Companies.
SAN MATEO, Calif., Jan. 09, 2025 (GLOBE NEWSWIRE) — Freshworks Inc. (NASDAQ: FRSH) will announce its financial results for the fourth quarter and full year ended December 31, 2024 following the close of market on Tuesday, February 11, 2025. Freshworks will host a live audio webcast beginning at 2:00 p.m Pacific Time / 5:00 p.m. Eastern Time that same day to discuss the company’s financial results and business highlights.
Event: Freshworks Fourth Quarter and Full Year 2024 Financial Results Date: Tuesday, February 11, 2025Time: 2:00 p.m. PT / 5:00 p.m. ETAudio webcast: https://ir.freshworks.com
A webcast replay will be accessible from the Freshworks investor relations website at https://ir.freshworks.com. The press release will be accessible from the Freshworks investor relations website prior to the commencement of the event.
About...
RAPT Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Written by Customer Service on . Posted in Public Companies.
SOUTH SAN FRANCISCO, Calif., Jan. 09, 2025 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients with inflammatory and immunological diseases, today announced that Brian Wong, M.D., Ph.D., President and Chief Executive Officer, will present a company overview at the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2025 at 9:00 a.m. Pacific Time.
To access the live webcast or subsequent archived recording of the company presentation, please visit the RAPT Therapeutics website at https://investors.rapt.com/events-and-presentations.
About RAPT Therapeutics, Inc.RAPT Therapeutics is a clinical-stage, immunology-based therapeutics company focused on discovering, developing...
Daré Bioscience to Participate in the Women’s Health Series at the 43rd Annual J.P. Morgan Healthcare Conference
Written by Customer Service on . Posted in Public Companies.
The panel will discuss the value proposition for investing in women’s health.
J.P. Morgan is hosting a three-panel women’s health series at this year’s conference to highlight the importance of innovation and growing visibility around women’s health.
SAN DIEGO, Jan. 09, 2025 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ: DARE), a leader in innovation for the health and wellbeing of women, announced today that Sabrina Martucci Johnson, President and CEO of Daré Bioscience, will be speaking on the ARPA-H | Investing in Women’s Health panel during the Women’s Health Series at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA. The panel will be on Tuesday, January 14th at 2:15 p.m. PT and will be followed by two additional panels focused on women’s health, The Future of Women’s Health Care and Flow of Capital...
Enphase Energy Expands in Latin America with Launch of IQ8 Microinverters in Colombia, Panama, and Costa Rica
Written by Customer Service on . Posted in Public Companies.
FREMONT, Calif., Jan. 09, 2025 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world’s leading supplier of microinverter-based solar and battery systems, today announced that it is expanding in Latin America with the launch of IQ8P™ Microinverters, with peak output AC power of 480 W, for residential and commercial applications in Colombia, Panama, and Costa Rica to support newer high-powered solar modules. Enphase is working with installers and distributors throughout Latin America, including the recent launch of IQ8™ Microinverters in the Caribbean, as well as ongoing operations in Brazil, Puerto Rico, and Mexico.
IQ8 Microinverters are designed to maximize energy production and can manage a continuous DC current of 14 amperes, supporting higher-powered solar...
Acumen Pharmaceuticals Announces Journal of Prevention of Alzheimer’s Disease Publication of the Company’s Phase 1 INTERCEPT-AD Study, Including Target Engagement, Dosing Regimen and Safety Findings
Written by Customer Service on . Posted in Public Companies.
Phase 1 INTERCEPT-AD data published in Journal of Prevention of Alzheimer’s Disease supports continued development of sabirnetug (ACU193) for treatment of early Alzheimer’s disease (AD)
Sabirnetug demonstrated selective, dose-dependent target engagement of amyloid beta oligomers (AβOs), statistically significant amyloid plaque reduction within higher dose cohorts, and low overall levels of ARIA-E
Phase 2 ALTITUDE-AD clinical trial of sabirnetug is ongoing with enrollment completion expected 1H 2025
NEWTON, Mass., Jan. 09, 2025 (GLOBE NEWSWIRE) — Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s disease (AD), today announced that the Journal of Prevention of Alzheimer’s Disease...
EagleBank Adds New Market Executive and Two Relationship Managers to C&I Lending Team
Written by Customer Service on . Posted in Public Companies.
Addition of experienced bankers in the DMV region complements EagleBank’s C&I growth strategy
BETHESDA, Md., Jan. 09, 2025 (GLOBE NEWSWIRE) — EagleBank (NASDAQ: EGBN), one of the largest community banks in the Washington, D.C. area, today announced that Bryan Pynchon will join the Bank as a C&I Market Executive for Maryland and Ian Joseph and Andrew Brkic as Relationship Managers (RMs) under Pynchon’s leadership, as of January 6, 2025. In their respective roles, the new team members will work to advance EagleBank’s goal of expanding its robust, diverse, and stable C&I portfolio.
“The talent that we put in front of clients is a point of pride for Eagle and adding Bryan, Ian and Andrew to the team will even further enhance our position as the go-to commercial lender in the Greater Washington community,” said Evelyn...